{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:06:18Z","timestamp":1784696778112,"version":"3.55.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liver metastases (LM) are clinically important in colon cancer, but routinely available clinicopathological and laboratory profiles associated with LM status remain incompletely characterized. This study aimed to identify clinical, pathological, and laboratory variables associated with LM status in patients with colon cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective observational study included patients with pathologically confirmed colon cancer diagnosed between January 2020 and December 2023. LM was identified by imaging and\/or histopathological confirmation. A pragmatic 1:2 non-propensity-score matching strategy was used to select non-LM controls. Univariable and multivariable logistic regression analyses were performed to evaluate variables associated with LM status. Sensitivity analyses and exploratory subgroup analyses of synchronous and metachronous LM were conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 756 eligible patients, 101 developed LM, yielding an incidence of 13.4%. The matched cohort included 101 LM patients and 202 controls. After adjustment, lymphovascular invasion (adjusted odds ratio [aOR] 2.57, 95% confidence interval [CI] 1.38\u20134.76; P\u00a0=\u00a00.003), perineural invasion (aOR 1.94, 95% CI 1.05\u20133.59; P\u00a0=\u00a00.035), N2 stage (aOR 2.48, 95% CI 1.17\u20135.25; P\u00a0=\u00a00.018), carcinoembryonic antigen (CEA) per doubling (aOR 1.72, 95% CI 1.42\u20132.10; P&amp;lt;0.001), and neutrophil-to-lymphocyte ratio (NLR) per 1-unit increase (aOR 1.35, 95% CI 1.15\u20131.59; P&amp;lt;0.001) were independently associated with LM status. Sensitivity analyses showed generally consistent findings. Synchronous LM was characterized by higher carcinoembryonic antigen and NLR levels than metachronous LM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LM status in colon cancer was associated with adverse pathological features, nodal burden, higher CEA levels, and higher NLR. These routinely available variables may serve as supportive clinical indicators for assessing hepatic involvement, but should not be interpreted as causal factors or as a validated prediction model.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1817217","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:41:52Z","timestamp":1784695312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and risk factors in patients with colon cancer liver metastases"],"prefix":"10.3389","volume":"16","author":[{"given":"Shan","family":"Ou","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.102926","article-title":"EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases","volume":"136","author":"Bregni","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2024.12.006","article-title":"Assessment and treatment considerations for patients with colorectal liver metastases: AHPBA consensus guideline and update for surgeons","volume":"27","author":"Yohanathan","year":"2025","journal-title":"HPB (Oxford)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1200\/jco.22.01690","article-title":"Treatment of metastatic colorectal cancer: ASCO guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2024.03.01","article-title":"CSCO guidelines for colorectal cancer version 2024: Updates and discussions","volume":"36","author":"Chen","year":"2024","journal-title":"Chin J Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000001236","article-title":"Personalized circulating tumor DNA monitoring improves recurrence surveillance and management after curative resection of colorectal liver metastases: a prospective cohort study","volume":"110","author":"Li","year":"2024","journal-title":"Int J Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.52661","article-title":"Circulating tumor DNA testing in curatively resected colorectal cancer and salvage resection","volume":"7","author":"Ji","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s44272-026-00062-6","article-title":"Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastasis (2025 edition)","volume":"5","author":"Fan","year":"2026","journal-title":"Clin Cancer Bull"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/20552076251388394","article-title":"Biomarker-based and interpretable machine learning framework for predicting pathological stage in gastric cancer: a retrospective analysis","volume":"11","author":"Liu","year":"2025","journal-title":"Digit Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2023.08.012","article-title":"Updated management of colorectal cancer liver metastases: Scientific advances driving modern therapeutic innovations","volume":"16","author":"Patel","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.02.006","article-title":"Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials","volume":"184","author":"Rossini","year":"2023","journal-title":"Eur J Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.14701\/ahbps.23-078","article-title":"Predictive modeling algorithms for liver metastasis in colorectal cancer: a systematic review of the current literature","volume":"28","author":"Seow-En","year":"2024","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16091645","article-title":"Clinical prediction models for prognosis of colorectal liver metastases: a comprehensive review of regression-based and machine learning models","volume":"16","author":"Kokkinakis","year":"2024","journal-title":"Cancers"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158002","article-title":"Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients","volume":"22","author":"Yamamoto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/11795549221084851","article-title":"Pretreatment inflammatory markers predict outcomes and prognosis in colorectal cancer patients with synchronous liver metastasis","volume":"16","author":"Li","year":"2022","journal-title":"Clin Med Insights Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102592","article-title":"Integrative multi-omics of matched primary and liver metastatic colorectal cancer organoids identifies putative molecular targets","volume":"63","author":"Kim","year":"2026","journal-title":"Transl Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/1073274821997418","article-title":"Predictive nomogram of subsequent liver metastasis after mastectomy or breast-conserving surgery in patients with nonmetastatic breast cancer","volume":"28","author":"Yang","year":"2021","journal-title":"Cancer Control"},{"key":"B17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12885-025-15285-4","article-title":"Early prediction of liver metastasis in pancreatic cancer using routine clinical data: an externally validated machine learning model","volume":"26","author":"Ko","year":"2025","journal-title":"BMC Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1186\/s12885-025-14083-2","article-title":"Lymphovascular invasion affects prognosis of colorectal cancer liver metastasis underwent primary resection: a propensity score matching analysis","volume":"25","author":"Li","year":"2025","journal-title":"BMC Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2024.109144","article-title":"Simultaneous curative resection may improve the long-term survival of patients diagnosed with colorectal liver metastases: a propensity score-matching study","volume":"181","author":"Shi","year":"2025","journal-title":"Surgery"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/cej.0000000000000859","article-title":"Meta-analysis of the prognostic value of serum carcinoembryonic antigen in patients with colorectal cancer liver metastases after hepatectomy","volume":"33","author":"Yuan","year":"2024","journal-title":"Eur J Cancer Prev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-084219","article-title":"Grading carcinoembryonic antigen levels can enhance the effectiveness of prognostic stratification in patients with colorectal cancer: a single-centre retrospective study","volume":"14","author":"Xie","year":"2024","journal-title":"BMJ Open"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa020","article-title":"Threshold change in CEA as a predictor of non-progression to first-line systemic therapy in metastatic colorectal cancer patients with elevated CEA","volume":"112","author":"Gulhati","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"B24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12935-023-02876-z","article-title":"The prognostic utility of preoperative neutrophil-to-lymphocyte ratio (NLR) in patients with colorectal liver metastasis: a systematic review and meta-analysis","volume":"23","author":"Li","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1408700","article-title":"Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review","volume":"15","author":"Tan","year":"2024","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-024-04800-x","article-title":"The impact of neoadjuvant therapy on the prognostic value of preoperative neutrophil-to-lymphocyte ratio for colorectal liver metastases: a multi-center cohort study","volume":"40","author":"Wang","year":"2025","journal-title":"Int J Colorectal Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152539","article-title":"Prognostic factors in colorectal liver metastases: an exhaustive review of the literature and future prospectives","volume":"17","author":"Conticchio","year":"2025","journal-title":"Cancers"},{"key":"B28","doi-asserted-by":"publisher","first-page":"10057","DOI":"10.1038\/s41598-024-60855-4","article-title":"Elevated serum homocysteine levels associated with poor recurrence-free and overall survival in patients with colorectal cancer","volume":"14","author":"Xie","year":"2024","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-010-9518-z","article-title":"Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer","volume":"28","author":"Yang","year":"2011","journal-title":"Med Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051239","article-title":"EOB-MR based radiomics analysis to assess clinical outcomes following liver resection in colorectal liver metastases","volume":"14","author":"Granata","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-023-00495-x","article-title":"Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics","volume":"18","author":"Granata","year":"2023","journal-title":"Infect Agent Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1817217\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:41:57Z","timestamp":1784695317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1817217\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":31,"alternative-id":["10.3389\/fonc.2026.1817217"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1817217","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1817217"}}